Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation.

Authors :: Niscola P
Grazia CD
Mazzone C
Tolu B
de Fabritiis P
Angelucci E
Source :: Blood research [Blood Res] 2019 Dec; Vol. 54 (4), pp. 288-290. Date of Electronic Publication: 2019 Dec 20.
Publication Year :: 2019
Abstract: Competing Interests: Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.

Full Text Access

Tools